| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 9e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 6e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |